CRP and interstitial lung disease: We previously reported that MDA5+ DM patients with high-RP-ILD risk were characterized by elevated CRP, lactate dehydrogenase (LDH), and ferritin at baseline compared with low or medium RP-ILD risk patients, supporting our current findings that a persistent and severe inflammatory response promotes lung injury.